Charles River Laboratories International (CRL) Competitors $151.95 +0.84 (+0.56%) Closing price 06/12/2025 03:59 PM EasternExtended Trading$149.62 -2.33 (-1.53%) As of 09:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, TMO, and AShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Charles River Laboratories International vs. Its Competitors Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International (NYSE:MTD) and Charles River Laboratories International (NYSE:CRL) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Is MTD or CRL more profitable? Mettler-Toledo International has a net margin of 22.29% compared to Charles River Laboratories International's net margin of 0.52%. Charles River Laboratories International's return on equity of 14.69% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Mettler-Toledo International22.29% -591.54% 26.78% Charles River Laboratories International 0.52%14.69%6.79% Do insiders & institutionals believe in MTD or CRL? 95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 1.9% of Mettler-Toledo International shares are owned by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts rate MTD or CRL? Mettler-Toledo International presently has a consensus price target of $1,302.11, indicating a potential upside of 9.37%. Charles River Laboratories International has a consensus price target of $171.85, indicating a potential upside of 13.09%. Given Charles River Laboratories International's higher probable upside, analysts clearly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mettler-Toledo International 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40Charles River Laboratories International 1 Sell rating(s) 12 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.18 Does the media favor MTD or CRL? In the previous week, Mettler-Toledo International and Mettler-Toledo International both had 10 articles in the media. Mettler-Toledo International's average media sentiment score of 1.46 beat Charles River Laboratories International's score of 0.60 indicating that Mettler-Toledo International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Charles River Laboratories International 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, MTD or CRL? Mettler-Toledo International has higher earnings, but lower revenue than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMettler-Toledo International$3.83B6.46$863.14M$40.1029.69Charles River Laboratories International$4.02B1.86$474.62M-$0.65-233.77 Which has more volatility and risk, MTD or CRL? Mettler-Toledo International has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Does the MarketBeat Community believe in MTD or CRL? Charles River Laboratories International received 124 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 59.52% of users gave Charles River Laboratories International an outperform vote while only 56.26% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformMettler-Toledo InternationalOutperform Votes37356.26% Underperform Votes29043.74% Charles River Laboratories InternationalOutperform Votes49759.52% Underperform Votes33840.48% SummaryMettler-Toledo International and Charles River Laboratories International tied by winning 8 of the 16 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE ExchangeMarket Cap$7.46B$3.36B$5.61B$19.88BDividend YieldN/A2.05%5.28%3.82%P/E Ratio1,013.00122.3027.1435.60Price / Sales1.86166.21414.3043.81Price / Cash7.4834.5738.2517.51Price / Book2.242.577.074.85Net Income$474.62M$118.81M$3.23B$1.02B7 Day Performance4.99%1.92%0.71%0.90%1 Month Performance5.24%9.03%9.65%2.35%1 Year Performance-28.47%-20.15%32.07%10.79% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.702 of 5 stars$151.95+0.6%$171.85+13.1%-28.9%$7.46B$4.02B1,013.0021,400MTDMettler-Toledo International3.743 of 5 stars$1,196.53+1.0%$1,302.11+8.8%-18.4%$24.87B$3.83B29.5218,000Positive NewsWATWaters4.1775 of 5 stars$348.56-0.7%$390.19+11.9%+16.0%$20.74B$2.98B32.558,200ILMNIllumina4.8983 of 5 stars$84.98+2.8%$128.84+51.6%-18.8%$13.45B$4.34B-11.0711,500Positive NewsAnalyst ForecastOptions VolumeTECHBio-Techne4.874 of 5 stars$49.88+2.4%$72.00+44.3%-33.5%$7.82B$1.21B50.383,000Positive NewsBIOBio-Rad Laboratories4.7767 of 5 stars$225.84+2.9%$324.25+43.6%-18.0%$6.15B$2.54B-3.478,200Analyst RevisionBRKRBruker4.9612 of 5 stars$39.21+2.4%$56.22+43.4%-39.8%$5.94B$3.45B51.598,520PACBPacific Biosciences of California2.2371 of 5 stars$1.20+5.3%$2.13+77.6%-40.4%$360.10M$152.36M-0.73730Positive NewsHBIOHarvard Bioscience3.9211 of 5 stars$0.56+36.5%$3.00+437.3%-82.4%$24.69M$91.40M-1.69490Trending NewsShort Interest ↑High Trading VolumeTMOThermo Fisher Scientific4.9763 of 5 stars$408.57+1.7%$605.30+48.2%-27.9%$154.23B$42.90B24.72130,000Positive NewsAAgilent Technologies4.6222 of 5 stars$116.77+0.8%$140.15+20.0%-10.7%$33.17B$6.51B28.8317,900 Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
